Your browser doesn't support javascript.
loading
Co-Administration Of iRGD Enhances Tumor-Targeted Delivery And Anti-Tumor Effects Of Paclitaxel-Loaded PLGA Nanoparticles For Colorectal Cancer Treatment.
Zhong, Yi; Su, Tao; Shi, Qiuxiao; Feng, Yanru; Tao, Ze; Huang, Qiuxia; Li, Lan; Hu, Liqiang; Li, Shengfu; Tan, Hong; Liu, Shan; Yang, Hao.
Afiliação
  • Zhong Y; Key Lab of Transplant Engineering and Immunology, MOH, West China-Washington Mitochondria and Metabolism Research Center, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
  • Su T; Key Lab of Transplant Engineering and Immunology, MOH, West China-Washington Mitochondria and Metabolism Research Center, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
  • Shi Q; Key Lab of Transplant Engineering and Immunology, MOH, West China-Washington Mitochondria and Metabolism Research Center, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
  • Feng Y; Key Lab of Transplant Engineering and Immunology, MOH, West China-Washington Mitochondria and Metabolism Research Center, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
  • Tao Z; Key Lab of Transplant Engineering and Immunology, MOH, West China-Washington Mitochondria and Metabolism Research Center, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
  • Huang Q; Key Lab of Transplant Engineering and Immunology, MOH, West China-Washington Mitochondria and Metabolism Research Center, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
  • Li L; Key Lab of Transplant Engineering and Immunology, MOH, West China-Washington Mitochondria and Metabolism Research Center, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
  • Hu L; Key Lab of Transplant Engineering and Immunology, MOH, West China-Washington Mitochondria and Metabolism Research Center, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
  • Li S; Key Lab of Transplant Engineering and Immunology, MOH, West China-Washington Mitochondria and Metabolism Research Center, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
  • Tan H; Department of General Surgery, Chengdu Integrated TCM & Western Medicine Hospital (Chengdu First People's Hospital), Chengdu 610041, People's Republic of China.
  • Liu S; Department of Laboratory Medicine, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 610072, People's Republic of China.
  • Yang H; Key Lab of Transplant Engineering and Immunology, MOH, West China-Washington Mitochondria and Metabolism Research Center, West China Hospital, Sichuan University, Chengdu 610041, People's Republic of China.
Int J Nanomedicine ; 14: 8543-8560, 2019.
Article em En | MEDLINE | ID: mdl-31802868
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Neoplasias Colorretais / Sistemas de Liberação de Medicamentos / Paclitaxel / Nanopartículas / Copolímero de Ácido Poliláctico e Ácido Poliglicólico Limite: Animals / Humans Idioma: En Revista: Int J Nanomedicine Ano de publicação: 2019 Tipo de documento: Article País de publicação: Nova Zelândia
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Neoplasias Colorretais / Sistemas de Liberação de Medicamentos / Paclitaxel / Nanopartículas / Copolímero de Ácido Poliláctico e Ácido Poliglicólico Limite: Animals / Humans Idioma: En Revista: Int J Nanomedicine Ano de publicação: 2019 Tipo de documento: Article País de publicação: Nova Zelândia